TRUADVICE’s Zimmer Biomet ZBH Stock Holding History

TRUADVICE’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,440	Closed	-$386K	–	297
2021 Q2	$386K	Buy	2,440 +52	+2%	+$8.42K	0.08%	210
2021 Q1	$414K	Buy	+2,388	New	+$370K	0.12%	164

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TRUADVICE's ZBH Position: Q3 2021 in Review

TRUADVICE sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 2,440 shares — an estimated $386K sold.

TRUADVICE first reported a position in ZBH in Q1 2021 and held it in 2 quarters. The position peaked at $414K in Q1 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

TRUADVICE reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
TRUADVICE sold 2,440 Zimmer Biomet shares in Q3 2021, an estimated $386K.
TRUADVICE first reported a position in Zimmer Biomet in Q1 2021 and held it in 2 quarters.
TRUADVICE's Zimmer Biomet position peaked at $414K in Q1 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on TRUADVICE's 13F filing for Q3 2021, filed 9 Nov 2021.